Webinar for Australasian Region “NEUROCOVID-19: Cognitive, Psychiatric, and Psychological Manifestations”

COVID-19 can affect the brain of infected individuals, which may result in a wide range of neurocognitive and neuropsychiatric symptoms. It can also have a profound psychological and psychiatric impact on the general population. In this webinar we will further discuss the concept of “neuro-COVID” and examine the expanding knowledge of its impact on specific brain systems. We will examine the causal role of neuro-COVID in dementia and delirium; in executive deficit, memory impairment and other specific cognitive impairments; in psychosis and psychiatric and psychological disorders; and its pediatric manifestations. We will also review the emerging therapeutic approaches, global research and clinical initiatives, and how one can participate in them.

The webinar features Elkhonon Goldberg, Ph.D., ABPP., a clinical neuropsychologist and cognitive neuroscientist, Clinical Professor in the Department of Neurology, NYU School of Medicine and Diplomate of The American Board of Professional Psychology in Clinical Neuropsychology. His critically acclaimed and bestselling books have been translated into 21 languages.

The webinar takes 3 hours.

Format:
Online webinar. The webinar will be recorded and the recording will be available to registrants for multiple reviews at their convenience after the live event.

Date and time:
July 17, 2021 (Saturday) from 1pm to 4pm Australian Eastern Standard Time

Fee:
US $165 for a three-hour webinar.

 
 

NEUROCOVID-19: Cognitive, Psychiatric, and Psychological Manifestations

Agenda
COVID-19 pandemic and the brain: a brief recap.
The impact of neuro-COVID on the frontal lobes, temporal lobes, brainstem, and other structures.
Specific types of cognitive impairment caused by neuro-COVID: executive deficit, amnestic syndromes, and others.
Delirium and dementia in neuro-COVID.
Psychiatric manifestations of neuro-COVID.
Psychosis in neuro-COVID.
Neuro-COVID in children.
Emerging therapeutic approaches.
Global initiatives.